Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy

Cancer Investigation
Corey J LangerJohn A Ridge

Abstract

Phase I study to determine the maximally tolerated dose (MTD) of cisplatin (cDDP), paclitaxel (P), and concurrent split course hyperfractionated (BID) RT in advanced squamous cell carcinoma of the head and neck (SCCHN) and other upper aerodigestive tumors. Eligibility stipulated ECOG performance status 0-2 and either Tx-naïve, locally advanced, or locally recurrent, previously radiated, surgically unresectable upper aerodigestive cancer. Metastases were permitted if disease was predominantly locoregional. RT-naïve patients received 150 cGy bid x 5 d Q 2 wks x 4. Previously radiated patients received 150 cGy bid x 5, wk 1; then 120 cGy bid x 5 Q 2 wk x 3 (later increased to 150 cGy BID for the entire treatment). Treatment fields included recurrent tumor only with 2 cm margins. Whenever possible, conventional and 3-D conformal techniques were used. Elective nodal radiation was not administered. Starting doses of cDDP and P were 12 mg/m2/d x 5 and 15 mg/m2/d x 5, respectively, Q 2 wk x 4, each given on RT days only. At dose level 2, cDDP was increased to 15 mg/m2/d x 5. At dose level 3, P was increased to 20 mg/m2/d x 5. Granulocyte colony stimulating factor (G-CSF) days 6-12 (off treatment week) was added if cumulative neutropeni...Continue Reading

References

Feb 20, 1992·The New England Journal of Medicine·C Schaake-KoningA Nijs
Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A ForastiereS K Williamson
Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C JacobsL Schacter
Oct 1, 1988·American Journal of Clinical Oncology·J PompW L van Putten
Jul 1, 1987·International Journal of Radiation Oncology, Biology, Physics·A A Puthawala, A M Syed
Jul 1, 1987·International Journal of Radiation Oncology, Biology, Physics·J J MazeronF Feuilhade
Aug 1, 1987·International Journal of Radiation Oncology, Biology, Physics·J J Mazeron
Jan 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D LangloisJ M Richard
May 1, 1980·The British Journal of Radiology·J SkołyszewskiM Reinfuss
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E E VokesR R Weichselbaum
Mar 16, 1994·Journal of the National Cancer Institute·J LiebmannJ B Mitchell
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·K R StevensW T Moss
Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Jun 1, 1993·Cancer·H ChoyD D Von Hoff

❮ Previous
Next ❯

Citations

Nov 23, 2013·Pakistan Journal of Biological Sciences : PJBS·Farshad SeyyednejadMohamad Goldust
Jan 20, 2010·Mutation Research·Cristiane Cademartori DanesiMauricio Lehmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.